Market Research Report

Global Sphingolipids Market Report By Product (Ceramide, Sphingomyelin, Glucosylceramide (GlcCer), Lactosylceramide (LacCer), Ganglioside GM3, Other), By Source (Synthetic, Semi-synthetic, Natural), By Application (Conventional Lipid-based Drug Delivery Systems (LBDDS), Self-Emulsifying Drug Delivery Systems (SEDDS), Self-Microemulsifying Drug Delivery Systems (SMEDDS), Liposomes, Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, Others), By Form (Liquid, Semi-solid, Solid), By End User (Pharmaceutical Companies, Biopharmaceutical Companies, Academics And Research Institutes, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11219582
November 2022
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Sphingolipids Market is presumed to reach the market size of nearly USD 1067.4 MN by 2028 from USD 664.5 MN in 2021 with a CAGR of 7% under the study period 2022 - 2028.

Sphingolipids are a diverse group of polar lipids found in cell membranes. It plays an important role in various cellular processes, including signalling, differentiation, and apoptosis. Sphingolipids have been essential in preventing pulmonary leaks and lung injury during the past several years, and altering their routes may be a method for therapeutic interventions. 

Market Dynamics 

The market for sphingolipid products is growing rapidly due to rapid molecular and biological customization in sphingolipid formulations. The growing demand for sphingolipids from various end-use industries such as skincare, haircare, and other applications fuels the market growth. Also, the increasing prevalence of cardiovascular diseases and an ageing population drive market growth. Moreover, the growing awareness about the benefits of sphingolipids and the rising disposable income of consumers drive market growth. Further, an emerging factor driving the expansion of the worldwide sphingolipids market is enhanced drug delivery technology through prescription medications. In addition, rising initiatives to promote the health benefits of sphingolipids products, and ongoing research and development in modifying novel sphingolipids formulations, are expected to drive the sphingolipids market.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of sphingolipids. The growth and trends of sphingolipids industry provide a holistic approach to this study. 

Market Segmentation

This section of the sphingolipids market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Product
  • Ceramide
  • Sphingomyelin
  • Glucosylceramide (GlcCer)
  • Lactosylceramide (LacCer)
  • Ganglioside GM3
  • Other

By Source
  • Synthetic
  • Semi-Synthetic
  • Natural

By Application
  • Conventional Lipid-Based Drug Delivery Systems (LBDDS)
  • Self-Emulsifying Drug Delivery Systems (SEDDS)
  • Self-Microemulsifying Drug Delivery Systems (SMEDDS)
  • Liposomes
  • Solid Lipid Nanoparticles
  • Nanostructured Lipid Carriers
  • Others

By Form
  • Liquid
  • Semi-Solid
  • Solid

By End User
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Academics And Research Institutes
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Sphingolipids market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Sphingolipids Market Share by Region (Representative Graph)

Global Sphingolipids Market Share
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the sphingolipids market include Merck KGaA, CordenPharma International, Lipoid GmbH, LARODAN AB, Croda International Plc., Biosynth, Santa Cruz Biotechnology, Inc., Creative Enzymes, CD Bioparticles, Cayman Chemical Company, and Biosolve BV. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Frequently Asked Questions (FAQs) about this Report

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . SPHINGOLIPIDS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Product
           3.7.2 Market Attractiveness Analysis By Source
           3.7.3 Market Attractiveness Analysis By Application
           3.7.4 Market Attractiveness Analysis By Form
           3.7.5 Market Attractiveness Analysis By End User
           3.7.6 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL SPHINGOLIPIDS MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical and Forecast Data
       6.3 Analysis by Product
       6.4 Ceramide Historic and Forecast Sales by Regions
       6.5 Sphingomyelin Historic and Forecast Sales by Regions
       6.6 Glucosylceramide (GlcCer) Historic and Forecast Sales by Regions
       6.7 Lactosylceramide (LacCer) Historic and Forecast Sales by Regions
       6.8 Ganglioside GM3 Historic and Forecast Sales by Regions
       6.9 Other Historic and Forecast Sales by Regions
 
7 . GLOBAL SPHINGOLIPIDS MARKET ANALYSIS BY SOURCE
       7.1 Overview by Source
       7.2 Historical and Forecast Data
       7.3 Analysis by Source
       7.4 Synthetic Historic and Forecast Sales by Regions
       7.5 Semi-synthetic Historic and Forecast Sales by Regions
       7.6 Natural Historic and Forecast Sales by Regions
 
8 . GLOBAL SPHINGOLIPIDS MARKET ANALYSIS BY APPLICATION
       8.1 Overview by Application
       8.2 Historical and Forecast Data
       8.3 Analysis by Application
       8.4 Conventional Lipid-based Drug Delivery Systems (LBDDS) Historic and Forecast Sales by Regions
       8.5 Self-Emulsifying Drug Delivery Systems (SEDDS) Historic and Forecast Sales by Regions
       8.6 Self-Microemulsifying Drug Delivery Systems (SMEDDS) Historic and Forecast Sales by Regions
       8.7 Liposomes Historic and Forecast Sales by Regions
       8.8 Solid Lipid Nanoparticles Historic and Forecast Sales by Regions
       8.9 Nanostructured Lipid Carriers Historic and Forecast Sales by Regions
       8.10. Others Historic and Forecast Sales by Regions
 
9 . GLOBAL SPHINGOLIPIDS MARKET ANALYSIS BY FORM
       9.1 Overview by Form
       9.2 Historical and Forecast Data
       9.3 Analysis by Form
       9.4 Liquid Historic and Forecast Sales by Regions
       9.5 Semi-solid Historic and Forecast Sales by Regions
       9.6 Solid Historic and Forecast Sales by Regions
 
10 . GLOBAL SPHINGOLIPIDS MARKET ANALYSIS BY END USER
       10.1 Overview by End User
       10.2 Historical and Forecast Data
       10.3 Analysis by End User
       10.4 Pharmaceutical Companies Historic and Forecast Sales by Regions
       10.5 Biopharmaceutical Companies Historic and Forecast Sales by Regions
       10.6 Academics And Research Institutes Historic and Forecast Sales by Regions
       10.7 Others Historic and Forecast Sales by Regions
 
11 . GLOBAL SPHINGOLIPIDS MARKET ANALYSIS BY GEOGRAPHY
       11.1. Top  Company Share Analysis
       11.2. Introduction
       11.3. North America Sales Analysis
           11.3.1. Overview, Historic and Forecast Sales Analysis
           11.3.2. North America By Segment Sales Analysis
           11.3.3. North America By Country Sales Analysis
           11.3.4. United State Sales Analysis
           11.3.5. Canada Sales Analysis
           11.3.6. Mexico Sales Analysis
       11.4. Europe Sales Analysis
           11.4.1. Overview, Historic and Forecast Sales Analysis
           11.4.2. Europe by Segment Sales Analysis
           11.4.3. Europe by Country Sales Analysis
           11.4.4. United Kingdom Sales Analysis
           11.4.5. France Sales Analysis
           11.4.6. Germany Sales Analysis
           11.4.7. Italy Sales Analysis
           11.4.8. Russia Sales Analysis
           11.4.9. Rest Of Europe Sales Analysis
       11.5. Asia Pacific Sales Analysis
           11.5.1. Overview, Historic and Forecast Sales Analysis
           11.5.2. Asia Pacific by Segment Sales Analysis
           11.5.3. Asia Pacific by Country Sales Analysis
           11.5.4. China Sales Analysis
           11.5.5. India Sales Analysis
           11.5.6. Japan Sales Analysis
           11.5.7. South Korea Sales Analysis
           11.5.8. Australia Sales Analysis
           11.5.9. Rest Of Asia Pacific Sales Analysis
       11.6. Latin America Sales Analysis
           11.6.1. Overview, Historic and Forecast Sales Analysis
           11.6.2. Latin America by Segment Sales Analysis
           11.6.3. Latin America by Country Sales Analysis
           11.6.4. Brazil Sales Analysis
           11.6.5. Argentina Sales Analysis
           11.6.6. Peru Sales Analysis
           11.6.7. Chile Sales Analysis
           11.6.8. Rest of Latin America Sales Analysis
       11.7. Middle East & Africa Sales Analysis
           11.7.1. Overview, Historic and Forecast Sales Analysis
           11.7.2. Middle East & Africa by Segment Sales Analysis
           11.7.3. Middle East & Africa by Country Sales Analysis
           11.7.4. Saudi Arabia Sales Analysis
           11.7.5. UAE Sales Analysis
           11.7.6. Israel Sales Analysis
           11.7.7. South Africa Sales Analysis
           11.7.8. Rest Of Middle East And Africa Sales Analysis
 
12 . COMPETITIVE LANDSCAPE OF THE SPHINGOLIPIDS COMPANIES
       12.1. Sphingolipids Market Competition
       12.2. Partnership/Collaboration/Agreement
       12.3. Merger And Acquisitions
       12.4. New Product Launch
       12.5. Other Developments
 
13 . COMPANY PROFILES OF SPHINGOLIPIDS INDUSTRY
       13.1. Company Share Analysis
       13.2. Market Concentration Rate
       13.3. Merck KGaA
           13.3.1. Company Overview
           13.3.2. Company Revenue
           13.3.3. Products
           13.3.4. Recent Developments
       13.4. CordenPharma International
           13.4.1. Company Overview
           13.4.2. Company Revenue
           13.4.3. Products
           13.4.4. Recent Developments
       13.5. Lipoid GmbH
           13.5.1. Company Overview
           13.5.2. Company Revenue
           13.5.3. Products
           13.5.4. Recent Developments
       13.6. LARODAN AB
           13.6.1. Company Overview
           13.6.2. Company Revenue
           13.6.3. Products
           13.6.4. Recent Developments
       13.7. Croda International Plc.
           13.7.1. Company Overview
           13.7.2. Company Revenue
           13.7.3. Products
           13.7.4. Recent Developments
       13.8. Biosynth
           13.8.1. Company Overview
           13.8.2. Company Revenue
           13.8.3. Products
           13.8.4. Recent Developments
       13.9. Santa Cruz Biotechnology Inc.
           13.9.1. Company Overview
           13.9.2. Company Revenue
           13.9.3. Products
           13.9.4. Recent Developments
       13.10. Creative Enzymes
           13.10.1. Company Overview
           13.10.2. Company Revenue
           13.10.3. Products
           13.10.4. Recent Developments
       13.11. CD Bioparticles
           13.11.1. Company Overview
           13.11.2. Company Revenue
           13.11.3. Products
           13.11.4. Recent Developments
       13.12. Cayman Chemical Company
           13.12.1. Company Overview
           13.12.2. Company Revenue
           13.12.3. Products
           13.12.4. Recent Developments
       13.13. Biosolve BV
           13.13.1. Company Overview
           13.13.2. Company Revenue
           13.13.3. Products
           13.13.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Product (USD MN)
  •  Ceramide Market Sales by Geography (USD MN)
  •  Sphingomyelin Market Sales by Geography (USD MN)
  •  Glucosylceramide (GlcCer) Market Sales by Geography (USD MN)
  •  Lactosylceramide (LacCer) Market Sales by Geography (USD MN)
  •  Ganglioside GM3 Market Sales by Geography (USD MN)
  •  Other Market Sales by Geography (USD MN)
  •  Analysis Market by Source (USD MN)
  •  Synthetic Market Sales by Geography (USD MN)
  •  Semi-synthetic Market Sales by Geography (USD MN)
  •  Natural Market Sales by Geography (USD MN)
  •  Analysis by Application (USD MN)
  •  Conventional Lipid-based Drug Delivery Systems (LBDDS) Market Sales by Geography (USD MN)
  •  Self-Emulsifying Drug Delivery Systems (SEDDS) Market Sales by Geography (USD MN)
  •  Self-Microemulsifying Drug Delivery Systems (SMEDDS) Market Sales by Geography (USD MN)
  •  Liposomes Market Sales by Geography (USD MN)
  •  Solid Lipid Nanoparticles Market Sales by Geography (USD MN)
  •  Nanostructured Lipid Carriers Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis by Form (USD MN)
  •  Liquid Market Sales by Geography (USD MN)
  •  Semi-solid Market Sales by Geography (USD MN)
  •  Solid Market Sales by Geography (USD MN)
  •  Analysis by End User (USD MN)
  •  Pharmaceutical Companies Market Sales by Geography (USD MN)
  •  Biopharmaceutical Companies Market Sales by Geography (USD MN)
  •  Academics And Research Institutes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Sphingolipids Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition
 
 LIST OF FIGURES
 
  •  Research Scope of Sphingolipids Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Sphingolipids Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Source
  •  Market Attractiveness Analysis by Application
  •  Market Attractiveness Analysis by Form
  •  Market Attractiveness Analysis by End User
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis Product (USD MN)
  •  Ceramide Market Sales by Geography (USD MN)
  •  Sphingomyelin Market Sales by Geography (USD MN)
  •  Glucosylceramide (GlcCer) Market Sales by Geography (USD MN)
  •  Lactosylceramide (LacCer) Market Sales by Geography (USD MN)
  •  Ganglioside GM3 Market Sales by Geography (USD MN)
  •  Other Market Sales by Geography (USD MN)
  •  Global Market Analysis by Source (USD MN)
  •  Synthetic Market Sales by Geography (USD MN)
  •  Semi-synthetic Market Sales by Geography (USD MN)
  •  Natural Market Sales by Geography (USD MN)
  •  Global Market Analysis by Application (USD MN)
  •  Conventional Lipid-based Drug Delivery Systems (LBDDS) Market Sales by Geography (USD MN)
  •  Self-Emulsifying Drug Delivery Systems (SEDDS) Market Sales by Geography (USD MN)
  •  Self-Microemulsifying Drug Delivery Systems (SMEDDS) Market Sales by Geography (USD MN)
  •  Liposomes Market Sales by Geography (USD MN)
  •  Solid Lipid Nanoparticles Market Sales by Geography (USD MN)
  •  Nanostructured Lipid Carriers Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by Form (USD MN)
  •  Liquid Market Sales by Geography (USD MN)
  •  Semi-solid Market Sales by Geography (USD MN)
  •  Solid Market Sales by Geography (USD MN)
  •  Global Market Analysis by End User (USD MN)
  •  Pharmaceutical Companies Market Sales by Geography (USD MN)
  •  Biopharmaceutical Companies Market Sales by Geography (USD MN)
  •  Academics And Research Institutes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top  Company Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
After Sales Support
24/7 Email Support

Clients

Testimonials